These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 18595880)

  • 1. C-reactive protein: a poor marker of cardiovascular disease risk in HIV+ populations with a high prevalence of elevated serum transaminases.
    Baum MK; Rafie C; Sales S; Lai S; Duan R; Jayaweera DT; Page JB; Campa A
    Int J STD AIDS; 2008 Jun; 19(6):410-3. PubMed ID: 18595880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The association of high-sensitivity c-reactive protein and other biomarkers with cardiovascular disease in patients treated for HIV: a nested case-control study.
    De Luca A; de Gaetano Donati K; Colafigli M; Cozzi-Lepri A; De Curtis A; Gori A; Sighinolfi L; Giacometti A; Capobianchi MR; D'Avino A; Iacoviello L; Cauda R; D'Arminio Monforte A
    BMC Infect Dis; 2013 Sep; 13():414. PubMed ID: 24004495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-sensitivity C-reactive protein levels in HIV-infected patients treated or not with antiretroviral drugs and their correlation with factors related to cardiovascular risk and HIV infection.
    Guimarães MM; Greco DB; Figueiredo SM; Fóscolo RB; Oliveira AR; Machado LJ
    Atherosclerosis; 2008 Dec; 201(2):434-9. PubMed ID: 18359028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Highly sensitive C-reactive protein, body mass index, and serum lipids in HIV-infected persons receiving antiretroviral therapy: a longitudinal study.
    Boger MS; Shintani A; Redhage LA; Mitchell V; Haas DW; Morrow JD; Hulgan T
    J Acquir Immune Defic Syndr; 2009 Dec; 52(4):480-7. PubMed ID: 19911471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of antiretroviral therapy on oxidative stress and cardiovascular risk: a prospective cross-sectional study in HIV-infected patients.
    Masiá M; Padilla S; Bernal E; Almenar MV; Molina J; Hernández I; Graells ML; Gutiérrez F
    Clin Ther; 2007 Jul; 29(7):1448-55. PubMed ID: 17825696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. C-reactive protein: a nontraditional serum marker of cardiovascular risk.
    de Ferranti SD; Rifai N
    Cardiovasc Pathol; 2007; 16(1):14-21. PubMed ID: 17218210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular risk factors and markers of myocardial injury and inflammation in people living with HIV in Nairobi, Kenya: a pilot cross-sectional study.
    Ahmed HA; Mohamed J; Akuku IG; Lee KK; Alam SR; Perel P; Shah J; Ali MK; Eskander S; Chung MH; Shah AS
    BMJ Open; 2022 Jun; 12(6):e062352. PubMed ID: 35667720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inverse linear associations between liver aminotransferases and incident cardiovascular disease risk: The PREVEND study.
    Kunutsor SK; Bakker SJ; Kootstra-Ros JE; Blokzijl H; Gansevoort RT; Dullaart RP
    Atherosclerosis; 2015 Nov; 243(1):138-47. PubMed ID: 26386210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of biomarkers of cardiovascular risk among HIV type 1-infected adolescents: role of soluble vascular cell adhesion molecule as an early indicator of endothelial inflammation.
    Syed SS; Balluz RS; Kabagambe EK; Meyer WA; Lukas S; Wilson CM; Kapogiannis BG; Nachman SA; Sleasman JW
    AIDS Res Hum Retroviruses; 2013 Mar; 29(3):493-500. PubMed ID: 23062187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of Inflammatory Biomarkers in the Prevalence and Incidence of Hypertension Among HIV-Positive Participants in the START Trial.
    Ghazi L; Baker JV; Sharma S; Jain MK; Palfreeman A; Necsoi C; Murray DD; Neaton JD; Drawz PE
    Am J Hypertens; 2020 Jan; 33(1):43-52. PubMed ID: 31800000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of high sensitivity C-reaction protein in non-insulin dependent diabetes mellitus patients with non-alcoholic fatty liver disease.
    Bi Y; Min M; Shen W; Deng P; Du Q; Dong M; Liu Y
    Int J Clin Exp Pathol; 2015; 8(7):8494-9. PubMed ID: 26339423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of Lower Adiponectin Plasma Levels, Increased Age and Smoking with Subclinical Atherosclerosis in Patients with HIV-1 Infection.
    Bellinati PQ; Alfieri DF; Flauzino T; Junior PFG; Rossi DJ; Breganó JW; Simão ANC; de Almeida ERD; Lozovoy MAB; Reiche EMV
    Curr HIV Res; 2020; 18(4):292-306. PubMed ID: 32516102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. C-reactive protein concentrations are very high and more stable over time than the traditional vascular risk factors total cholesterol and systolic blood pressure in an Australian aboriginal cohort.
    Shemesh T; Rowley KG; Jenkins AJ; Best JD; O'Dea K
    Clin Chem; 2009 Feb; 55(2):336-41. PubMed ID: 19074519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The cardiovascular risk marker asymmetric dimethylarginine is elevated in asymptomatic, untreated HIV-1 infection and correlates with markers of immune activation and disease progression.
    Hudson CL; Zemlin AE; Ipp H
    Ann Clin Biochem; 2014 Sep; 51(Pt 5):568-75. PubMed ID: 24142400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated alanine aminotransferase levels in HIV-infected persons without hepatitis B or C virus coinfection.
    Alghamdi S; Alrbiaan A; Alaraj A; Alhuraiji A; Alghamdi M; Alrajhi A
    Ann Saudi Med; 2016; 36(4):288-91. PubMed ID: 27478915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between elevated coffee consumption and daily chocolate intake with normal liver enzymes in HIV-HCV infected individuals: results from the ANRS CO13 HEPAVIH cohort study.
    Carrieri MP; Lions C; Sogni P; Winnock M; Roux P; Mora M; Bonnard P; Salmon D; Dabis F; Spire B;
    J Hepatol; 2014 Jan; 60(1):46-53. PubMed ID: 23978720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of severe hepatic events associated with nevirapine-containing regimens: CD4+ T-cell count and gender in hepatitis C seropositive and seronegative patients.
    Torti C; Costarelli S; De Silvestri A; Quiros-Roldan E; Lapadula G; Cologni G; Paraninfo G; Castelnuovo F; Puoti M; Carosi G;
    Drug Saf; 2007; 30(12):1161-9. PubMed ID: 18035868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liver damage underlying unexplained transaminase elevation in human immunodeficiency virus-1 mono-infected patients on antiretroviral therapy.
    Ingiliz P; Valantin MA; Duvivier C; Medja F; Dominguez S; Charlotte F; Tubiana R; Poynard T; Katlama C; Lombès A; Benhamou Y
    Hepatology; 2009 Feb; 49(2):436-42. PubMed ID: 19085967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of Abnormal Liver Function Parameters with HIV Serostatus and CD4 Count in Antiretroviral-Naive Rwandan Women.
    Dusingize JC; Hoover DR; Shi Q; Mutimura E; Rudakemwa E; Ndacyayisenga V; Gakindi L; Mulvihill M; Sinayobye JD; Musabeyezu E; Anastos K
    AIDS Res Hum Retroviruses; 2015 Jul; 31(7):723-30. PubMed ID: 25924728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-sensitivity C-reactive protein is only weakly related to cardiovascular damage after adjustment for traditional cardiovascular risk factors.
    Olsen MH; Christensen MK; Hansen TW; Gustafsson F; Rasmussen S; Wachtell K; Borch-Johnsen K; Ibsen H; Jørgensen T; Hildebrandt P
    J Hypertens; 2006 Apr; 24(4):655-61. PubMed ID: 16531793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.